Director, Cerebrovascular Surgery, University of Maryland Medical System; Medical Director, Neurological Surgery Intensive Care Unit, University of Maryland Medical System
22 S Greene Street
Education and Training
- 1970-1971: Undergraduate, Basic Sciences, University of the Orange Free State, Republic of South Africa (R.S.A.)
- 1972-1976: M.B. Ch.B. (cum laude), Faculty of Medicine, University of the Orange Free State, R.S.A.
- 1980-1983: FCS (S.A.), Neurosurgery, Department of Neurosurgery, University of the Orange Free State, R.S.A.
- 1984: M.Med. (cum laude), Department of Neurosurgery, University of the Orange Free State, R.S.A.
- 1986: FMGEMS and ECFMG English Test
- 1988: Federal Licensing Exam (FLEX)
- 1980-1984: Resident, Neurosurgery, University of the Orange Free State, Bloemfontein, Republic of South Africa
Dr. Aldrich joined the Department of Neurosurgery at the University of Maryland in 1993 after six years on the faculty at the University of Texas Medical Branch in Galveston. He has over 30 years neurosurgical experience were he has dedicated his career to the microsurgical treatment of a wide variety of complex neurosurgical cases in adults. He has consistently received many ‘U.S. News, Top Doc’ awards and is regularly included in the ‘America’s Best Physicians’ list. Dr. Aldrich is a Professor of Neurosurgery, Vice Chair of the Department of Neurosurgery, Residency Program Director and has served on the institutional review board for the last 20 years.
He is the head of cerebrovascular surgery and is an expert in the surgical treatment of ruptured and unruptured cerebral aneurysms as well as other brain blood vessel abnormalities. This is also the main focus of his clinical research. He is heavily involved in the design, and execution of multiple multinational studies in the treatment vasospasm, a potentially fatal condition that follows aneurysmal subarachnoid hemorrhage. New surgical techniques are being investigated for the treatment of interventricular and intracerebral hemorrhage. He also serves has the principal investigator on many of these studies.
Additionally, he has diverse clinical cranial neurosurgical interests as outlined below. Although the majority of his clinical work is cranial in nature, he has a very specific long standing interest in the treatment of degenerative complex cervical spinal disorders in adults.
Clinical: Cerebrovascular Surgery (Aneurysm, AVM, Intracerebral hemorrhage), Brain Tumors, Skull Based Tumors including Pituitary Tumors, MVD for Trigeminal Neuralgia and Hemifacial Spasm, Arnold Chiari Malformations Syringomyelia, Benign Spinal Tumors and Complex Cervical Spine Disease. Research: Dr. Aldrich’s research is centered around cerebral vascular diseases including multiple clinical trials relating to subarachnoid hemorrhage (Edge, Head Sense) and interventricular hemorrhage (CLEAR), intracerebral hemorrhage (MISTIE).
Hänggi D, Etminan N, Macdonald RL, Steiger HJ, Mayer SA, Aldrich F, Diringer MN, Hoh BL, Mocco J, Strange P, Faleck HJ, Miller M,: NEWTON: NimodipineMicroparticles to Enhance Recovery While Reducing Toxicity After Subarachnoid Hemorrhage, Neurocritical Care, 2015 Oct 23. doi: 10.1007/s12028-015-0112-2.
Webb AJ, Ullman NL, Morgan TC, Muschelli J, Kornbluth J, Awad IA, Mayo S, Rosenblum M, Ziai W, Zuccarrello M, Aldrich F, John S, Harnof S, Lopez G, Broaddus WC, Wijman C, Vespa P, Bullock R, Haines SJ, Cruz-Flores S, Tuhrim S, Hill MD, Narayan R, Hanley DF; MISTIE and CLEAR Investigators,: Accuracy of the ABC/2Score for Intracerebral Hemorrhage: Systematic Review and Analysis of MISTIE, CLEAR-IVH, and CLEAR III, Stroke, a journal of cerebral circulation, 2015 Sep. doi: 10.1161/STROKEAHA.114.007343
Aldrich EF: Posterior approach for cervical monoradiculopathy caused by posterolateral soft cervical disk sequestrations. Trans of the Amer Assoc of Neurol Surg Washington, DC:1989.
Bracken MB, Shepard MJ, Holford TR, Leo-Summers L, Aldrich EF, Fazl M, Fehlings M, Herr DL, Hitchon PW, Marshall LF, Nockels RP, Pascale V, Perot PL Jr, Piepmer JM, Sonntag VKHJ, Wagner F, Wilberger JE, Winn HR, Young W: Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury: Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial-National Acute Spinal Cord Injury Study, JAMA 277:1597-1604, 1997.
Yenokyan G, Ziai W, Thompson R, Mayo S, Dlugash R, Lane K, McBee N, Higb S, Harnof S, Lopez G, Aldrich EF, Harrigan M, Awad I, Hanley D; Intraventricular Hemorrhage Recovery: Change in disability and function at Year 1, for Clear Investigators 2014 Nov 5.
Webb AJ, Ullman NL, Morgan TC, Muschelli J, Kornbluth J, Awad IA, Mayo S, Rosenblum M, Ziai W, Zuccarrello M, Aldrich F, John S, Harnof S, Lopez G, Broaddus WC, Wijman C, Vespa P, Bullock R, Haines SJ, Cruz-Flores S, Tuhrim S, Hill MD, Narayan R, Hanley DF; MISTIE and CLEAR Investigators,: Accuracy of the ABC/2 Score for Intracerebral Hemorrhage: Systematic Review and Analysis of MISTIE, CLEAR-IVH, and CLEAR III, Stroke, a journal of cerebral circulation, 2015 Sep. doi: 10.1161/STROKEAHA.114.007343